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Abstract
Canaloplasty is a non-penetrating glaucoma surgery used to treat patients with open-angle glaucoma. It was 
developed as an alternative method to traditional glaucoma surgery and is one of the recent techniques of non-
penetrating glaucoma surgery. Studies have shown its efficacy and safety in the reduction of intraocular pressure, 
having a lower rate of intraoperative and post-operative complications compared to trabeculectomy. A combination of 
canaloplasty with phacoemulsification represents a good option for patients with concomitant cataract. Canaloplasty 
appears to be a good alternative for the treatment of open-angle glaucoma.
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Introduction
Glaucoma is the main cause of irreversible 
blindness in the world. The global prevalence of 
glaucoma in the population aged 40–80 years old 
is 3.54%. In 2013, it was estimated that there were 
64.3 million people suffering from glaucoma (40–80 
years old), which are expected to reach 76 million in 
2020 and 1118 million in 2040 [1].
Open-angle glaucoma constitutes 90% 
of cases with glaucoma in the USA and Europe. 
Raised intraocular pressure (IOP) remains the 
main risk factor for glaucoma and also the target of 
treatment as lowering of IOP is the only proven way 
of slowing down or halting the progression of the 
disease [2], [3], [4], [5], [6], [7],  [8]. Medications, laser 
treatments, or surgery can be used for this purpose. 
There are different surgical techniques, trabeculectomy 
still being considered the gold standard in the surgical 
treatment of glaucoma. Nowadays, newer techniques 
include non-penetrating glaucoma surgeries, such as 
deep sclerectomy, viscocanaloplasty, and recently 
canaloplasty.
Ab externum canaloplasty is a non-filtering, 
bleb-free method aiming to restore the natural 
conventional aqueous outflow pathway. This is believed 
to be achieved by catheterization of the Schlemm’s canal. 
Thinking to achieve a 360° widening of the Schlemm’s 
canal, a special catheter was developed, leading to 
the new surgical technique and canaloplasty. During 
this procedure, the catheter is used to pass a suture 
through the entire circumference of the Schlemm’s 
canal, which, after being tied, exerts a centripetal force 
in the inner wall of the Schlemm’s canal. Consequently, 
the canal remains open. The surgery can be performed 
in any quadrant of the sclera, although the superior 
part is preferred one. Canaloplasty can be performed 
under local or general anesthesia, depending on the 
surgeon’s preference.
Surgical technique
A fornix-based conjunctival peritomy and 
dissection of the conjunctiva are performed. A parabolic 
scleral flap measuring 5 × 5 mm is created. The 
parabolic shape makes the watertight closure at the 
end of the procedure more effective. A crescent knife is 
used to dissect the flap, which has to be approximately 
about 1/3 of the scleral thickness (200–300 µm). The 
flap has to reach the clear cornea anteriorly (Figure 1).
 Then, the second internal flap is created, being 
1 mm smaller than the superior one. The crescent knife 
helps again to advance the flap dissection anteriorly 
toward the Schlemm’s canal. The choroid remains 
covered by a very thin layer of the sclera (Figure 2). 
Finding the proper plane of the dissection is very 
important. Going too deep will lead to perforation. Going 
too superficial would lead the flap over the Schlemm’s 
canal itself, without going through it. If this happens, 
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a new deeper dissection needs to be done. The 
identification of anatomical structures is critical at this 
point. The scleral spur fibers run parallel to the limbus. 
Once the scleral spur fibers are visualized, we check 
for the external wall of the Schlemm’s canal under 
the deep flap. A paracentesis is performed to reduce 
the intraocular pressure, preventing the Descemet 
membrane bulging, and making the further dissection 
anteriorly more safe and easy. The dissection is 
extended for further 1 mm anteriorly, exposing the 
Figure 1: Creation of the superficial scleral flap
Descemet membrane. A thin strip of tissue from 
the internal wall of the Schlemm’s canal is removed using 
a Mermoud forceps. This is believed to increase the 
perfusion of aqueous through the trabeculo-Descemet 
window. The Descemet membrane has to be clear of 
corneal tissue. An excess of pressure exerted at this 
point, even from a dry sponge, could easily perforate 
the trabeculo-Descemet membrane. This is the reason 
for which the tip of the sponge should always be wet. A 
minimal amount of BSS (balanced salt solution) is used 
for this purpose. Once the trabeculo-Descemet window 
is created, the deep flap is amputated using Vannas 
scissors. A small amount of high viscosity sodium 
hyaluronate is injected in each of the Schlemm’s canal 
ends (Figure 3), making the catheterization easier. 
Figure 3: Injection of viscoelastic in both ends of the Schlemm’s canal
The catheter is passed through 360° of 
Schlemm’s canal circumference (Figure 4). A 10–0 
Prolene suture is tied at the leading tip, and the 
catheter is withdrawn backward until it comes out 
from the insertion end of the Schlemm’s canal. The 
suture comes out also, being passed through the 
whole circumference of the canal. The catheter is 
removed, and the suture ends are tied in a slipknot 
fashion (Figure 5). It is believed that the suture exerts 
a similar effect to pilocarpine, increasing the aqueous 
flow through the Schlemm’s canal and its collector 
channels. The tension that the suture exerts plays a 
very important role in the final result of canaloplasty [9]. 
Stegmann canal expander can be implanted in the 
Schlemm’s canal instead of the tensioning suture. The 
superficial scleral flap is sutured in its initial position 
(Figure 6), using five interrupted sutures (10–0 nylon or 
10–0 vicryl). The aim is to achieve a watertight closure 
of the flap (Figure 6). A scleral lake is created under 
Figure 2: Creation of the deep scleral flap Figure 4: Insertion of glauconite catheter in the Schlemm’s canal
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the scleral flap. High viscosity sodium hyaluronate is 
preferred to be injected under the scleral flap before its 
closure. This helps to keep the space open. Watertight 
closure of the conjunctiva with 10–0 vicryl suture 
remains the last step of the surgery.
Figure 6: Watertight closure of the superficial scleral flap
Types of catheters
Up to date, there are two different catheters 
that can be used to perform canaloplasty:
1. iTrack (iScience International, Menlo Park, 
California, USA) was the first developed 
one. It is composed of three main parts: The 
microcatheter (with a diameter of 250 µm at the 
tip and 200 µm at the half) the Viscoinjector, and 
the illumination source. The microcatheter has 
a lumen inside, through which the viscoelastic 
is injected to widen the Schlemm’s canal.
2. Glaucolight (DORC International, Zuidland, 
The Netherlands) is another type of catheter 
developed after iTrack was used. It has a 
thinner microcatheter with a diameter of 150 
µm. It does not have a lumen for the injection 
of the viscoelastic substance; therefore, it does 
not aim to inject viscoelastic through the whole 
circumference of the Schlemm’s canal.
Discussion
It is a well-known that trabeculectomy is 
still considered the gold standard procedure for 
the treatment of glaucoma, despite the high rate of 
complications related to the penetrating nature of the 
technique. Consequently, non-penetrating glaucoma 
surgery was developed. Sclerectomy was introduced, 
followed by viscocanalostomy and later canaloplasty.
Canaloplasty was first performed by Lewis et al. 
in 2007. This technique was designed to enhance the 
outflow of aqueous humor by dilating SC, establishing 
circumferential flow, and stretching out the trabecular 
meshwork. The effect on IOP reduction seemed to be 
correlated with suture tension, so many researchers 
tried to measure the distension of Schlemm’s canal 
created by the suture. Lewis et al. applied a grading 
system for suture tension measurement. After 2 years 
of follow-up, he observed that there was a 31% IOP 
reduction in the group with an evident post-operative 
distension, compared to 20% reduction in the group 
without such a one [10].
Bradao et al. used ultrasound biomicroscopy 
(UBM) and anterior segment optic coherence 
tomography (OCT) to measure Schlemm’s canal 
distension pre-operatively, 12 and 36 months post-
operatively. The conclusion was that suture tension 
contributed to IOP reduction. Both equipments 
were equally efficient in the identification of the 
structures [11]. Another mechanism proposed as 
contributing to the reduction of IOP after canaloplasty 
is enhanced aqueous humor filtration across the 
sclera and conjunctiva. Mastropasqua et al. showed 
that conjunctival microcysts had a four-fold increase 
measured with confocal laser-scanning microscopy 
before and after the surgery [12].
The effect of canaloplasty on IOP is reported 
by many studies. Data reported by Lewis et al. show 
clear IOP reduction after canaloplasty in glaucoma 
patients [9], [10], [13]. Grieshaber et al. have also 
observed the reduction of IOP following canaloplasty 
but with lower complete success rates 3 years after 
surgery compared to 1 year after surgery [14], [15].
Comparative studies that investigate 
trabeculectomy versus canaloplasty show a 
greater reduction of IOP in patients who have 
undergone trabeculectomy, but higher complication 
rates [16], [17], [18].
Figure 5: Tying of the tensioned suture
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Correct patient selection is the key to 
canaloplasty success [19]. Canaloplasty is mainly 
advised for open-angle glaucoma patients, including 
patients with pigmentary and pseudoexfoliative 
glaucoma, but also for angle-closure glaucoma patients 
who are undergoing or have previously undergone 
lensectomy. Canaloplasty is mainly indicated for 
patients with mild-to-moderate primary open-angle 
glaucoma and a low-to-mid-IOP target [20]. It is 
also indicated for patients with advanced glaucoma 
who is not good candidates for trabeculectomy [19]. 
Many surgeons prefer it for contact lens users due 
to the lack of the conjunctival bleb, which could be 
traumatized by the chronic friction of lens over the bleb. 
It is advised for the fellow eye in patients who have 
gone through serious complications in the other eye 
having undergone trabeculectomy. It is preferred for 
young patients, thinking to keep the list of other more 
aggressive techniques for later during life.
The safety profile is similar to the rates reported 
after classic non-penetrating glaucoma surgery [21]. 
The most common adverse effect reported by Lewis 
et al.is microhyphema in the first post-operative day 
(3,19 %), followed by IOP spikes, Descemet membrane 
detachment, hypotonia, choroidal effusion, and exposed 
suture. Iris prolapse has been reported by Shingleton 
et al. (1,9%), and one case of Bilateral Descemet 
membrane detachment has been reported by Palmiero 
et al. [22]. Few cases of Prolene suture erosion in the 
anterior chamber have also been reported.
Conclusions
Canaloplasty gives a satisfactory IOP 
reduction, with less intraoperative and post-operative 
complications compared to trabeculectomy, making it 
a preferred type of surgery for patients with a higher 
risk of complications. Ab externum canaloplasty has 
recently advanced toward ab interno canaloplasty, 
which eliminates the trauma to the conjunctiva. Further 
studies will be needed to evaluate the effectiveness of 
ab interno canaloplasty.
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